Using genome sequencing & machine learning to modernize infectious disease diagnosis and treatment

COMPANY

Antibiotic resistance is creating a public health crisis. Patients with a severe infection can die within hours, but current diagnostics for antibiotic resistance take 2 days or longer. At DZD, we are developing a rapid, whole genome sequencing-based diagnostic that identifies the strain and antibiotic resistance profile of a bacterial infection within hours. We are located at the Pagliuca Harvard Life Lab and Harvard iLab and we have a strong collaboration with the lab of Dr. Doug Kwon at the Ragon Institute of MGH, MIT and Harvard.


TEAM

Jong Lee, MBA

President & CEO, Co-founder

Founder at Incyte Medical Consulting, SVP Marketing & Strategy at ConforMIS, Management Consultant at Monitor Group. Studied at Harvard '93, Harvard Business School ‘99.

Doug Kwon, MD, PhD

Clinical Lead, Co-founder

Infectious Disease physician at Mass. General Hospital. Assistant Professor at Harvard Medical School. Director of Clinical Research at Ragon Institute of MGH, MIT and Harvard. Studied at Harvard '93, NYU '04 MD, PhD.

Melis Anahtar, MD, PhD

Biomedical Lead, Co-founder

Clinical Pathology resident at Mass. General Hospital. Studied at MIT '08, Oxford '09, Harvard '15 PhD and Harvard-MIT HST '17 MD. Rhodes Scholar, Soros Fellow, MSTP Fellow.

Miriam Huntley, PhD

Genomics Lead, Co-founder

Studied at MIT '09, Harvard '16. PhD in Applied Math focused on computational approaches to genomic analysis in complex biological systems. NSF GRFP Fellow.

Dougal Maclaurin, PhD

Software Lead, Co-founder

Studied at U. of Melbourne '08, '10, Harvard '16. PhD focused on machine learning as part of Harvard Intelligent Probabilistic Systems group. Frank Knox Fellow.

Ian Herriott

Lab Technologist

University of California, Berkeley, '03. B.S. Molecular Environmental Biology. Managed Sequencing Core at Universtiy of Alaska, Fairbanks.


WE'RE HIRING


NEWS

May 31 2017

MedTech Innovator Announces Startups Selected for Global Accelerator
DZD One of 20 participants in the industry’s premier accelerator

May 23 2017

MassChallenge Boston Announces 2017 Accelerator Cohort
DZD selected from over 1,500 applicants to participate in program

Mar 10 2017

Finalists Named in Harvard President's Innovation Challenge
DZD named one of 5 healthcare finalists in innovation challenge

Feb 12 2017

Harvard Innovation Labs Story: Miriam Huntley
Miriam interviewed on the Harvard Innovation Labs podcast

Nov 9 2016

Life Lab Builds on Cross-disciplinary Approach
Day Zero Diagnostics featured in opening ceremony of the Pagliuca Harvard Life Lab

Aug 23 2016

Kwon Awarded MGH DOM Innovation Grant
The Kwon Lab wins innovation grant to pursue bacterial resistance diagnostics

Aug 2 2016

Here Are 8 Digital Health Startups to Watch in Boston
BostInno features Day Zero Diagnostics as a startup to watch

Mar 23 2016

Day Zero Diagnostics Named 2016 HBSAB New Venture Competition Winner
DZD wins Harvard Business School Association of Boston Alumni New Venture Contest


AWARDS

Winner, New England Region (2016)

Winner, Pilot Innovation Grant (2016)

Venture in Residence, Harvard iLab & Life Lab (2016-2017)

Audience Choice, MIT Sloan Healthcare Innovation Prize (2017)

Winner, Boston Pitch Competition (2017), MedTech Innovator Accelerator (2017)

Finalist, Harvard President's Innovation Challenge (2017)

Finalist, MassChallenge Accelerator Program (2017)

info@dayzerodiagnostics.com

Harvard Innovation Lab, Batten Hall, 125 Western Ave, Allston, MA 02163

Copyright © 2017 Day Zero Diagnostics Inc.